Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

Marco Tartaglia(Icahn School of Medicine at Mount Sinai), Charlotte M. Niemeyer(University of Freiburg), Alessandra Fragale(Istituto Superiore di Sanità), Xiaoling Song(Icahn School of Medicine at Mount Sinai), Jochen Buechner(University of Freiburg), Andreas Jung(Friedrich-Alexander-Universität Erlangen-Nürnberg), Karel Hählen(Erasmus MC - Sophia Children’s Hospital), Henrik Hasle(Aarhus University Hospital), Jonathan D. Licht(Icahn School of Medicine at Mount Sinai), Bruce D. Gelb(Icahn School of Medicine at Mount Sinai)
Nature Genetics
April 28, 2003
10.1038/ng1156
Cited by 1,038

Abstract

Related Papers

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Marco Tartaglia, Ernest L. Mehler, Rosalie Goldberg et al.|Nature Genetics|2001|1.7k
Crystal Structure of the Tyrosine Phosphatase SHP-2
Peter Hof, Scott Pluskey, Sirano Dhe‐Paganon et al.|Cell|1998|1k
PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity
Marco Tartaglia, Kamini Kalidas, Adam Shaw et al.|The American Journal of Human Genetics|2002|795
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
Gideon Bollag, D. Wade Clapp, Shane Shih et al.|Nature Genetics|1996|608
Hypertelorism With Turner Phenotype
Jacqueline A. Noonan|American journal of diseases of children|1968|543